Squamous cell carcinoma is the second most common skin malignancy in the United States, and its incidence steadily rises each year, posing a significant public health concern. Mortality rates for cutaneous squamous cell carcinoma are comparable to those of melanoma, renal carcinoma, and oropharyngeal carcinoma in the central and southern regions of the United States. Timely surveillance, early diagnosis, and prompt treatment are critical to minimize morbidity and mortality risks. Although surgical excision remains the cornerstone of treatment, ongoing research brings novel therapeutic approaches. In addition, nonsurgical options, such as radiation therapy, topical creams, cryotherapy, photodynamic therapy, and laser ablation, are available, especially for patients unsuitable for surgery. However, these nonsurgical treatments often have higher recurrence rates.Regular skin examinations and frequent follow-ups are recommended by healthcare providers, particularly for high-risk patients, to facilitate early detection and treatment, highlighting the importance of collaborative care for optimal management. Diagnosis usually requires a skin biopsy, with advanced cases often necessitating additional imaging and sentinel lymph node biopsy. This activity covers the etiology, epidemiology, pathophysiology, histopathological subtypes, clinical features, and management options for cutaneous squamous cell carcinoma. This activity emphasizes the critical role of photoprotection in reducing the risk of developing cutaneous squamous cell carcinoma due to its strong association with UV radiation. Therefore, this activity underscores the importance of interprofessional collaboration among healthcare providers in counseling patients on preventive measures, such as practicing photoprotection through sun avoidance, using SPF 30 sunscreen, and wearing protective clothing and sunglasses.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/29094
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - MOC Credit Details: ABS - 1.5 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.5 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.5 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.5 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABOHNS - 1.5 Point; Credit Type(s): Self-Assessment (ABOHNS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Complex General Surgical Oncology, Dermatopathology, General Pediatrics, General Surgery, Head & Neck, Internal Medicine, Medical Oncology, Molecular Genetic Pathology, Pediatric Hematology-Oncology, Surgical Pathology